14822 Federal Register / Vol. 72, No.
60 / Thursday, March 29, 2007 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Workshop to Discuss Development of
a Women’s Health Information Sharing
Network
AGENCY: Food and Drug Administration,
HHS.
ACTION: Notice of meeting.
The Food and Drug Administration’s
(FDA’s) Office of Women’s Health is
announcing the following meeting:
‘‘Workshop to Develop a Women’s
Health Information Sharing Network’’ to
discuss opportunities for national
organizations to share information about
their women’s health education
activities. There will be two meetings.
One will focus on Hispanic/Latina
populations, and the other will focus on
all other communities. Representatives
of national community-based
organizations are invited. A continental
breakfast will be provided.
Date and Time: The meetings will be
held on April 12 and 13, 2007, from
8:30 am to 11:30 am.
Location: The meetings will be held at
AARP, 601 East St., NW., Washington,
DC 20049.
Contact: Susana Perry, FDA Office of
Women’s Health (HF–8), Food and Drug
Administration, 5600 Fishers Lane, rm.
16–65, Rockville, MD 20857, 301–827–
0350, FAX: 301–827–9194, e-mail:
susana.perry@fda.hhs.gov.
Registration: There is no fee, but pre-
registration is required for security
purposes by AARP. Seating is limited to
20 participants for each meeting.
If you need special accommodations
due to a disability, please contact
Susana Perry at least 7 days in advance
(by April 6, 2007).
Dated: March 23, 2007.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. 07–1546 Filed 3–27–07; 8:50 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Survey of Complementary and
Alternative Medicine Use by United
States Cancer Patients Comment
Period
jlentini on PROD1PC65 with NOTICES
AGENCY: National Cancer Institute (NCI),
National Institutes of Health (NIH),
Department of Health and Human
Services (HHS).
VerDate Aug<31>2005 17:20 Mar 28, 2007 Jkt 211001
ACTION: Request for public comment.
SUMMARY: In compliance with the
provisions of section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comments on
proposed data collection projects, the
National Institutes of Health (NIH),
National Cancer Institute (NCI) will
publish periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
DATES: The National Survey of Cancer
CAM Researchers’ Recommendations
public comment period will run from
May 1, 2007 to June 30, 2007.
ADDRESSES: Comments may be
submitted electronically at http://
www.cancer.gov/cam.
Background: Title: National Survey of
Complementary and Alternative
Medicine Use by United States Cancer
Patients. Type of Information Collection
Request: New. Need and Use of
Information Collection: There have been
many regional surveys conducted about
the use of CAM by cancer patients, but
only one national survey which was
published in 1992 The NCI is seeking to
determine whether it should make an
investment in the gathering of current
nationally representative data on cancer
patients’ use of CAM.
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies are invited
on one or more of the following points:
(a) Whether nationally representative
data should be obtained on CAM use by
U.S. cancer patients; (b) the type of data
about CAM use by U.S. cancer patients
which should be considered high
priority; (c) whether international data
on CAM use by cancer patients should
be collected; and (d) appropriate uses
for any data on CAM use by cancer
patients that is collected.
Dated: February 28, 2007.
Shea Buckman,
NCI OCCAM Communications and Outreach
Manager, National Institutes of Health.
[FR Doc. E7–5832 Filed 3–28–07; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute, Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 E:\FR\FM\29MRN1.SGM
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung
and Blood Institute Special Emphasis Panel,
Research Project in Drug Therapy.
Date: April 26, 2007.
Time: 10:30 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person:: Mark Roltsch, PhD,
Scientific Review Administrator, Review
Branch/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7192, Bethesda, MD 20892–7924, 301–435–
0287, roltschm@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Disease Research; 93.839, Blood Diseases and
Resources Research, National Institutes of
Health, HHS)
Dated: March 22, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–1548 Filed 3–28–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
29MRN1
 Federal Register / Vol. 72, No. 60 / Thursday, March 29, 2007 / Notices
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Research Projects in Longitudinal Studies of
HIV.
Date: May 3, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Georgetown Suites, 1111 30th Street,
NW., Washington, DC 20007.
Contact Person: Holly Patton, PhD,
Scientific Review Administrator, Review
Branch/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7188, Bethesda, MD 20892–7924, 301–435–
0280, pattonh@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Loan Repayment Program (L30).
Date: May 31, 2007.
Time: 10 a.m. to 1 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Valerie L. Prenger, PhD,
Chief, Review Branch, Review Branch/DERA,
National Heart, Lung, and Blood Institute,
6701 Rockledge Drive, Room 7214, Bethesda,
MD 20892–7924, 301–435–0270,
prengerv@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: March 23, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–1550 Filed 3–28–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Advisory Council for Human
Genome Research.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
jlentini on PROD1PC65 with NOTICES
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
VerDate Aug<31>2005 17:20 Mar 28, 2007 Jkt 211001
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Human Genome Research.
Date: May 21–22, 2007.
Open: May 21, 2007, 8:30 a.m. to 3 p.m.
Agenda: To discuss matters of program
relevance.
Place: National Institutes of Health, 5635
Fishers Lane, Terrace Level Conferrence
Room, Bethesda, MD 20892.
Closed: May 21, 2007, 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health, 5635
Fishers Lane, Bethesda, MD 20892.
Closed: May 22, 2007, 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health, 5635
Fishers Lane, Bethesda, MD 20892.
Contact Person: Mark S. Guyer, PhD,
Director for Extramural Research, National
Human Genome Research Institute, 5635
Fishers Lane, Suite 4076, MSC 9305,
Bethesda, MD 20892, 301–496–7531,
guyerm@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: http://
www.genome.gov/11509849, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: March 22, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–1547 Filed 3–28–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 E:\FR\FM\29MRN1.SGM
14823
is hereby given of a meeting of the
Division of Intramural Research Board
of Scientific Counselors, NIAID. The
meeting will be closed to the public as
indicated below with the provisions set
forth in sections 552b(c)(6), Title 5
U.S.C., as amended for the review,
discussion, and evaluation of individual
intramural programs and projects
conducted by the National Institute of
Allergy and Infectious Diseases,
including consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Division of Intramural
Research Board of Scientific Counselors,
NIAID.
Date: June 4–5, 2007.
Time: June 4, 2007, 8 a.m. to 5 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 50, 50 Center Drive, Conference
Rooms, 1227/1233, Bethesda, MD 20892.
Time: June 5, 2007, 8 a.m. to 12 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 50, 50 Center Drive, Conference
Rooms 1227/1233, Bethesda, MD 20892.
Contact Person: Kathryn C. Zoon, PhD,
Director, Division of Intramural Research,
National Institute of Allergy, and Infectious
Diseases, NIH, Building 31, Room 4A30,
Bethesda, MD 20892, 301–496–3006,
kzoon@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: March 22, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–1553 Filed 3–28–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Library of Medicine; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
29MRN1